Literature DB >> 31201593

Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids.

Zichang Ma1, Hiroshi Ozaki2, Yojiro Ishikawa1, Keiichi Jingu3.   

Abstract

PURPOSE: To evaluate the effectiveness of radiation therapy and steroids for Asian patients with Graves' ophthalmopathy using the clinical activity score (CAS), and changes in external ocular muscles and eye proptosis determined by magnetic resonance imaging (MRI).
MATERIALS AND METHODS: We retrospectively reviewed 48 patients who received combined orbital radiation and systemic glucocorticoids in our hospital. MRI was performed both before and 1 month after treatment in all patients. We calculated the areas of five extraocular muscles and the degree of proptosis on transverse sections, and we evaluated the activity of the disease using CAS before and 1 month after treatment and toxicity.
RESULTS: The areas of external ocular muscles, the length of eye prominence and CAS were significantly improved by the combination of orbital radiation and steroids. The change in the area of the medial rectus muscle had a significant correlation with the change in CAS (P < 0.05). Graves' ophthalmopathy progressed again in 4 of the 48 patients; however, there were no patients with serious side effects in a median observation period of 41.5 months.
CONCLUSION: Treatment with the combination of orbital radiation and systemic glucocorticoids is subjectively and objectively effective for Asian Graves' ophthalmopathy without severe toxicity.

Entities:  

Keywords:  Extraocular muscle; Graves’ ophthalmopathy; Magnetic resonance imaging; Radiation therapy; Steroids

Mesh:

Substances:

Year:  2019        PMID: 31201593     DOI: 10.1007/s11604-019-00846-y

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  22 in total

1.  Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial.

Authors:  G J Kahaly; H P Rösler; S Pitz; G Hommel
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Dominant infiltration of T(H)1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy.

Authors:  D Yang; Y Hiromatsu; T Hoshino; Y Inoue; K Itoh; K Nonaka
Journal:  Thyroid       Date:  1999-03       Impact factor: 6.568

3.  Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?

Authors:  Zsolt Szucs-Farkas; Judit Toth; Erzsebet Balazs; Laszlo Galuska; Kenneth D Burman; Zsolt Karanyi; Andras Leovey; Endre V Nagy
Journal:  AJR Am J Roentgenol       Date:  2002-10       Impact factor: 3.959

4.  The use of corticosteroids versus other treatments for Graves' ophthalmopathy: a quantitative evaluation.

Authors:  Sheikha Abalkhail; Suhail A R Doi; Kamal A S Al-Shoumer
Journal:  Med Sci Monit       Date:  2003-11

5.  Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.

Authors:  Iris M M J Wakelkamp; Hendra Tan; Peerooz Saeed; Reinier O Schlingemann; Frank D Verbraak; Leo E C M Blank; Mark F Prummel; Wilmar M Wiersinga
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

6.  Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease.

Authors:  E J Mayer; D L Fox; G Herdman; J Hsuan; J Kabala; P Goddard; M J Potts; R W J Lee
Journal:  Eur J Radiol       Date:  2005-10       Impact factor: 3.528

7.  Place of radiotherapy in the treatment of Graves' orbitopathy.

Authors:  V Beckendorf; T Maalouf; J L George; P Bey; J Leclere; E Luporsi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

Review 8.  Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  Thyroid       Date:  2002-03       Impact factor: 6.568

9.  Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.

Authors:  Kenji Ohtsuka; Akihiko Sato; Satoshi Kawaguchi; Masato Hashimoto; Yasuo Suzuki
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

10.  A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.

Authors:  Mark F Prummel; Caroline B Terwee; Martin N Gerding; Lelio Baldeschi; Maarten P Mourits; Leo Blank; Friedo W Dekker; Wilmar M Wiersinga
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

View more
  1 in total

1.  Monitoring and Predicting Treatment Response of Extraocular Muscles in Grave's Orbitopathy by 99mTc-DTPA SPECT/CT.

Authors:  Chengzhi Jiang; Zilong Deng; Jin Huang; Haoyu Deng; Jia Tan; Xinhui Li; Min Zhao
Journal:  Front Med (Lausanne)       Date:  2021-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.